Reflections on Innovation, Science, and Society

Similar documents
The Shape of Things to Come: Massachusetts June 18, 2010 Newton Marriott Hotel

2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award

At A Glance. - Wendell Weeks, Chairman, CEO, and President

LC/MS/MS. Page Header. triple quadrupole mass spectrometer.

At A Glance. - Wendell Weeks, Chairman, CEO, and President

Venture Capital Search Highlights

Pharmaceutical Products and Services

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Corporate Mind 2016 Corporate Responsibility Report

CHINA MED DEVICE. China Medtech Will Continue Its Double Digit Growth in Years to Come

WHO WE ARE MISSION STATEMENT

Taking a broader view

IBM Research Your future is our concern IBM Corporation

Driving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Why Artificial Intelligence will Revolutionize Healthcare including the Behavioral Health Workforce.

INTEL INNOVATION GENERATION

Challenges of Inclusive Growth

The Power of Exponential Thinking

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

Model Based Design Of Medical Devices

Research & Development in Delaware. Delaware. Olivier Letessier, VP R&D Air Liquide Henri Chevrel, VP R&D Americas Air Liquide THIS DOCUMENT IS PUBLIC

Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO

The Sherwin-Williams Company

Lupin Limited Annual Results FY12. Investor Presentation May being

NEWS RELEASE. Life sciences companies tout their expertise in India

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Funding New Innovations

Making your Best Bet for US Market Success

Health Innovation Manchester

Utrecht Region. A key role in the Netherlands medical technology industry. Why locate your medical technology company in the Utrecht Region?

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

Coatings technology overview

Technology Transfers Opportunities, Process and Risk Mitigation. Radhika Srinivasan, Ph.D. IBM

Digital Medical Device Innovation: A Prescription for Business and IT Success

ALL RAW MATERIALS ARE NOT CREATED EQUAL.

FT-IR.

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Corporate Mind 2013 Corporate Responsibility Report

Pharma Clean Assurance Programme.

ACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017

THE PILLARS THAT SUPPORT US

Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Fresenius Medical Care North America (FMCNA)

Make an Executive Decision to Fight Cancer.

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Welcome to Althea. Welcome to the future of integrated healthcare technology management

DIGITAL FINLAND FRAMEWORK FRAMEWORK FOR TURNING DIGITAL TRANSFORMATION TO SOLUTIONS TO GRAND CHALLENGES

Utrecht Region. At the heart of the Netherlands Life Sciences and Health industry. Why locate your life sciences company in the Utrecht Region?

Digitalization and TITLE OF. Devices May 2018 PRESENTATION

The New Imperative: Collaborative Innovation. Dr. Anil Menon Vice President, Corporate Strategy IBM Growth Markets

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

We will exceed your expectations

Maximising R&D Impact with Better External Validations of projects value Propositions

COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the

Understanding User Needs in Low-Resource Settings for Diagnostics Development

FDA Centers of Excellence in Regulatory and Information Sciences

Pharmaceutical Manufacturing and Engineering Catalog Excerpt

The Foundry Model is Coming to Molecular Diagnostics, Courtesy of the Semiconductor Industry.

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

Asia Conference Singapore

Health technology translation from lab to market from the perspective of Diagnostics (Dx) Innovator

EU s Innovative Medical Technology and EMA s Measures

Trends in Healthcare Investments and Exits 2018

Europe s Digital Agenda and Industry 4.0 A revolution in the making. Andrea Renda

Boundaryless Hospital - Rethink and Redefine Health Care Management. New Chains of Value Creation

INVENT, INNOVATE AND IMPACT THE FUTURE CAREERS AT SRI: CENTER FOR VISION TECHNOLOGIES

Biocommercialization: Providing Enabling Policy Environments

Roche in Mannheim. The high-tech campus

Molecular Pathology. Theme: Exploring the clinical practices and research ideas in the field of molecular Pathology. Molecular Pathology 2019

USTGlobal. 3D Printing. Changing the Face of Healthcare

IBM Research Zurich. A Strategy of Open Innovation. Dr. Jana Koehler, Manager Business Integration Technologies. IBM Research Zurich

COM C. Rozwell

The robots are coming, but the humans aren't leaving

Research Guidance. GE Global Research. Design for Breakthrough Research In an Academic Settings GCEP. November 11, 2005

Climate Change Innovation and Technology Framework 2017

KANSAS BIOSCIENCE INDEX 2008

National Instruments Accelerating Innovation and Discovery

KNOW TRAINING MORE WITH. PerkinElmer Training Catalogue 2013 Relevant, interactive, rich in content.

Automotive Sector What is our interest in CAV & ITS and Why? Nigel J Francis

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Tecan Group. Corporate Update CONFERENCE CALL JANUARY 15, 2019

Nano4Health. February 14 th Lieve Apers Coordinator Nano4Health

Post Show Report. 16 th International exhibition for laboratory equipment and chemical reagents April 2018 ECC Sokolniki, Moscow, Russia

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper

SOLUTIONS WITH INSIGHT

Navigating The Fourth Industrial Revolution: Is All Change Good?

Health & Social Care Industrial Innovation

Corporate Mind 2015 Corporate Responsibility Report

Fujitsu, SMU, and A*STAR collaborate on traffic management technologies with the Maritime and Port Authority of Singapore

What could be driving the Lab of the future and is the Smart Lab really a thing?

Making lives better every day. This is UCB

Accelerating Growth and Cost Reduction in the PV Industry

FET in H2020. European Commission DG CONNECT Future and Emerging Technologies (FET) Unit Ales Fiala, Head of Unit

THE LONG VIEW IN BRIEF

Investor Presentation. May 2016

EXPERIENCE INDUSTRY X.0. At the Detroit Industry X.0 Innovation Center

Transcription:

Reflections on Innovation, Science, and Society Klaus Lindpaintner CSO, Thermo Fisher Scientific 1 The world leader in serving science

So: What is Innovation? Is it technology? A sociocultural and socioeconomcal phenomenon based on technology Technology: essential, but not sufficient 2

Innovation Definition: Application of new solutions that meet new requirements, inarticulate needs, or existing market needs Requirements: A recognized (or unrecognized/anticipated) need, Competent people with relevant technology Financial support Attributes Sustaining: An innovation that does not affect existing markets. Evolutionary Revolutionary Disruptive: An innovation that creates a new market 3

4

Innovation Definition: Application of new solutions that meet new requirements, inarticulate needs, or existing market needs Requirements: A recognized (or unrecognized/anticipated) need, Competent people with relevant technology Financial support Attributes Sustaining: An innovation that does not affect existing markets. Evolutionary Revolutionary Disruptive: An innovation that creates a new market 5

Effective Innovation: Stakeholders Contribution Genius revolutionary Opportunities/Need for Public-Private-Partnerships Reduction to Practice sustaining Societal Change disruptive 6

Sustaining Innovation Evolutionary: An innovation that improves a product in an existing market in ways that customers are (+/-) expecting potential to add tremendous value Revolutionary (discontinuous, radical): An innovation that is unexpected, but nevertheless does not affect existing markets 7

Disruptive Innovation Innovation that creates a new market by applying a different set of values, which ultimately and unexpectedly overtakes an existing market. 8

Sustaining Innovation Evolutionary: Revolutionary (discontinuous, radical): 9

Disruptive Innovation 10

The notorious sigmoid curve 11

Surfing the curve keeping ahead of it 12

Sustaining Innovation creates value 13

Sustaining and Disruptive Innovation B.C. 1500 1870 14

Disruptive Innovation creates Dilemmas 15

Sustaining and Disruptive Innovation B.C. 1500 1870 1870 16

before it creates value 17

Sustaining and Disruptive Innovation B.C. 1500 1870 18 1870 1902 1902

Relative prevalence of technology Life cycles of disruptive innovation Sailing Vessels Steam Ships Diesel Engines 19

Sustaining Inovatoin Extension 20

Disruptive Innovation 21

Can lessons be learned to surf the wave of Innovation? Hedging bets, balancing risks 1968: QEII launched as a steamship hindsight is 20/20 1986: Diesel retrofit 22

Relative prevalence of technology Life cycles of disruptive innovation Sailing Vessels Steam Ships Diesel Engines 23

Innovation happens in many walks of life why focus on technology? 24

Technology innovation drives other innovation 25

Same raw material technology adds value Big Bang ca. 10,000 BC ca. 2000 AD 26

Key Players in Research, Science, Innovation Academic Institutions Innovationdriven Industry Enablers -Scientific Instruments -Quality reagents and consumables -Informatics -Services 27

Science Enabling Companies: A 60B Industry 3 % 3 % 4 % 5 % 6 % 9 % 3 % 3 % 3 % 37 % Mol & Cell Biology Tools & Reagents Diagnostic and Clincal Supply Separations General Laboratory Disposables Microscopy and Surface Analysis Molecular Spectroscopy Atomic Spectroscopy Mass Spectrometry General Analytical Tools Lab Automation Materials Testing and Characterization Lab Equipment 9 % 15 % > 3B in annual R&D spending 28

Number of Publications in Nature-Science Family Critical Role of Innovation in Analytical Technologies New generation Mass Spectrometry technology (Orbitrap) Older generation MS technology Advances in instrumentation propel breakthrough science 29

World s Biggest Analytical Challenges Future Needs Small Sample Amounts Greater Resolution Complex Matrices Complicated Structures Better Sensitivity Large Sample Numbers Point Of Need Analysis Low Concentration Always ready Measurements Faster, Higher Throughput Ease of Use Lower cost position Generalist Workforce Needs at all levels of price and performance 30

Innovation does not happen in a vacuum Academia Universities, Research Centers, Hospitals Opportunities/Need for Public-Private-Partnerships Industry Enabling Production Logistics Society Funding, Regulatory, End-Users 31

Innovation in Health Care Academia Basic& Clinical Research Opportunities/Need for Public-Private-Partnerships Industry BioPharma Diagnostics Enabling Society Patients Providers Payors Patents 32

We Are the World Leader in Serving Science Global Scale* 50,000 employees in 50 countries $17 billion in annual revenues Unparalleled commercial reach Ranking of ~170 on Fortune 500 Unmatched Depth Innovative technologies Applications expertise Lab productivity partner Industry-leading Brands We enable our customers to make the world healthier, cleaner and safer 33 * Thermo Fisher standalone: 39,000 employees, $13B revenue, Ranked 220 on Fortune 500

Thermo Fisher Scientific Global Presence Note: As of December 31, 2011. 34

Diverse Customers, Product Mix & Geographic Reach Balanced and diverse customer base Strong recurring revenue mix Growing presence in emerging markets Healthcare Pharma & Diagnostics & Biotech 26% 25% Industrial & Applied 27% Academic & Government 22% Services 14% Instruments, Equipment & Software 30% Consumables 56% ROW 4% Asia- Pacific 17% Europe 25% North America 54% End Markets Products Geographies 35 Note: Revenue based on LTM through Q1 2013.

Our Scale and Unique Depth of Capabilities Revenue Leading portfolio of high-value specialty diagnostic tests to improve patient care Specialty Diagnostics 23% Analytical Technologies 31% Laboratory Products and Services 46% Industry-leading offering to increase laboratory productivity Innovative technologies to solve complex analytical challenges 36 Note: Revenue based on LTM through Q1 2013. Percentages calculated before inter-company eliminations.

Technology and Innovation Leadership: The World s One and Only Pan-Omics Provider Research and Discovery Production Applied Markets Specialty Diagnostics Protein sample prep Laboratory consumables Research chemicals Single-use bioprocess technologies Cell factories Food safety Environmental Biomarkers Transplant Microbiology Allergy Mass spectrometry Liquid chromatography Spectroscopy Cell biology Molecular biology reagents Sera and media Chromatography Forensics Animal health Cancer Infectious disease Next-generation sequencing q-pcr Capillary electrophoresis Unique ability to accelerate customer innovation 37

Continued Innovation is essential, because: If you prepare for tomorrow, tomorrow will come. If you don t prepare for tomorrow, tomorrow will come African proverb klaus.lindpaintner@thermofisher.com 38 The world leader in serving science

We Enable Our Customers to Make the World 39